These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32089242)

  • 1. Another coronavirus, another epidemic, another warning.
    Poland GA
    Vaccine; 2020 Feb; 38(10):v-vi. PubMed ID: 32089242
    [No Abstract]   [Full Text] [Related]  

  • 2. Annelies Wilder-Smith.
    Kirby T
    Lancet Infect Dis; 2020 Aug; 20(8):907. PubMed ID: 32738242
    [No Abstract]   [Full Text] [Related]  

  • 3. Calling it what it is.
    Nat Genet; 2020 Apr; 52(4):355. PubMed ID: 32246133
    [No Abstract]   [Full Text] [Related]  

  • 4. 2019 Novel coronavirus infection and gastrointestinal tract.
    Gao QY; Chen YX; Fang JY
    J Dig Dis; 2020 Mar; 21(3):125-126. PubMed ID: 32096611
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 6. New coronavirus: new challenges for pediatricians.
    Chen ZM; Fu JF; Shu Q
    World J Pediatr; 2020 Jun; 16(3):222. PubMed ID: 32037473
    [No Abstract]   [Full Text] [Related]  

  • 7. From SARS to COVID-19: the Singapore journey.
    Lin RJ; Lee TH; Lye DC
    Med J Aust; 2020 Jun; 212(11):497-502.e1. PubMed ID: 32474940
    [No Abstract]   [Full Text] [Related]  

  • 8. Ensuring global access to COVID-19 vaccines.
    Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK
    Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19: Perspectives on the Potential Novel Global Threat.
    Gentile I; Abenavoli L
    Rev Recent Clin Trials; 2020; 15(2):84-86. PubMed ID: 32116200
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil.
    Garcia LP; Duarte E
    Epidemiol Serv Saude; 2020 Apr; 29(2):e2020222. PubMed ID: 32294756
    [No Abstract]   [Full Text] [Related]  

  • 11. The coronavirus pandemic in five powerful charts.
    Callaway E; Cyranoski D; Mallapaty S; Stoye E; Tollefson J
    Nature; 2020 Mar; 579(7800):482-483. PubMed ID: 32203366
    [No Abstract]   [Full Text] [Related]  

  • 12. The Rapid Assessment and Early Warning Models for COVID-19.
    Bai Z; Gong Y; Tian X; Cao Y; Liu W; Li J
    Virol Sin; 2020 Jun; 35(3):272-279. PubMed ID: 32239446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Coronavirus Disease Outbreak: The Italian Trends.
    Abenavoli L; Cinaglia P; Luzza F; Gentile I; Boccuto L
    Rev Recent Clin Trials; 2020; 15(2):87-92. PubMed ID: 32264813
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronavirus: why a permanent ban on wildlife trade might not work in China.
    Ribeiro J; Bingre P; Strubbe D; Reino L
    Nature; 2020 Feb; 578(7794):217. PubMed ID: 32047312
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 16. AI systems aim to sniff out coronavirus outbreaks.
    Cho A
    Science; 2020 May; 368(6493):810-811. PubMed ID: 32439771
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 18. Communication, collaboration and cooperation can stop the 2019 coronavirus.
    Nat Med; 2020 Feb; 26(2):151. PubMed ID: 32015560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Viral City to Smart City: Learning from Pandemic Experiences.
    Sakellarides C
    Acta Med Port; 2020 Jun; 33(6):359-361. PubMed ID: 32304373
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management guidelines for vulnerable workers and persons and SARS-CoV-2 in Catalonian businesses].
    Grupo de trabajo Grupo de trabajo para la elaboración de criterios para la gestión de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluña.GTPSVTESSARS-CoV-2
    Arch Prev Riesgos Labor; 2020 Apr; 23(2):234-252. PubMed ID: 32320546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.